STOCK TITAN

Nexgel Stock Price, News & Analysis

NXGL NASDAQ

Company Description

Company Overview

Nexgel Inc is a specialized manufacturer of advanced hydrogel solutions, known for its high water content, electron beam cross-linked, aqueous polymer gels. With a strong foundation in transdermal delivery, advanced hydrogel, and medical diagnostics, the company originally developed its unique transdermal delivery system for the hospital wound care market and has since expanded its portfolio to include consumer over-the-counter (OTC), prescription (Rx), medical device, and cosmetic applications. Central to its operation is a commitment to leveraging proprietary and non-proprietary mixing, coating, and cross-linking technologies that allow for the creation of custom gels tailored to the specific requirements of various application areas.

Technology and Innovation

Nexgel Inc utilizes state-of-the-art manufacturing techniques to produce gels that stand out for their consistency and reliability. These advanced hydrogels are produced through an electron beam cross-linking process that ensures high water content and durability, making them ideal for sensitive medical applications. The use of proprietary technology not only enables the customization of gel properties but also provides the company with a competitive edge by offering versatile solutions that can be adapted to intricate clinical, diagnostic, and cosmetic needs.

Market Applications

The company has a diverse range of applications that span multiple market segments. Initially established in the hospital wound care sector, Nexgel Inc’s products have gained regulatory approval for use in critical care settings, establishing a strong track record in healthcare. Its products are now widely deployed in:

  • Wound Care: Utilizing high water content gels to provide effective and soothing wound management solutions.
  • Transdermal Drug Delivery: Enabling efficient and controlled drug delivery through the skin, addressing both therapeutic and diagnostic needs.
  • Medical Diagnostics: Offering gels that support functionalities in diagnostic devices, contributing to enhanced reliability and sensitivity.
  • Cosmetic Applications: Providing innovative cosmetic products that benefit from the unique properties of hydrogels for skin care and aesthetic treatments.

This multifaceted approach underscores the company’s ability to serve a wide range of customers, from hospitals and healthcare providers to consumers in the cosmetic industry.

Competitive Landscape

Nexgel Inc operates within a competitive arena where precision in manufacturing and technological innovation are paramount. Its focus on proprietary gel formulation processes allows for significant customization—an important differentiator in a market that values both reliability and specialized performance. By consistently leveraging deep technical knowledge and advanced production methods, the company establishes a clear market differentiation despite operating alongside other firms in the hydrogel and medical device sectors.

Strategic Position and Business Model

The business model of Nexgel Inc is built around manufacturing and licensing its specialized gel technology. The company generates revenue by catering to both niche and large-scale demands across multiple segments, including medical, diagnostic, and cosmetic applications. Its ability to provide custom solutions reinforces its strategic position, blending innovation with a proven technology track record. Through a combination of direct sales and strategic partnerships, Nexgel Inc ensures that its advanced hydrogel solutions remain relevant and continually integrated into diverse applications.

Quality and Regulatory Adherence

A core strength of Nexgel Inc lies in its commitment to quality and regulatory compliance. The technology, initially approved for hospital use, sets a solid benchmark for safety and efficacy. This adherence to stringent standards not only underpins product reliability but also builds enduring trust with stakeholders in both the healthcare and consumer markets.

Innovation in Custom Solutions

In an industry that demands precision and adaptability, Nexgel Inc's custom gel solutions are a testament to its innovative approach. The company’s ability to tailor the physical and chemical properties of its products to meet specific industry needs showcases its expertise and flexibility. Whether for enhancing the performance of transdermal drug delivery devices or creating advanced cosmetic formulations, Nexgel Inc remains focused on optimizing its approach to deliver consistent, high-quality products.

Conclusion

Overall, Nexgel Inc offers a comprehensive suite of advanced hydrogel solutions that intersect critical areas of healthcare, diagnostics, and cosmetics. Its reliance on proprietary technology and deep industry know-how ensures a robust and diversified product portfolio. With a focus on both custom and scalable production, the company addresses complex market needs while maintaining a strong adherence to quality and regulatory standards. This multifaceted operational structure makes Nexgel Inc an intriguing study in the convergence of advanced materials science and practical applications across multiple high-demand sectors.

Stock Performance

$2.50
-1.19%
0.03
Last updated: April 27, 2025 at 15:59
98.22 %
Performance 1 year
$19.2M
Market Cap
7.7M
Shares outstanding

SEC Filings

No SEC filings available for Nexgel.

Financial Highlights

$8,688,000
Revenue (TTM)
-$3,463,000
Net Income (TTM)
-$0.50
Diluted EPS (TTM)
-$3,867,000
Operating Cash Flow
-39.86%
Net Profit Margin
-40.91%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Nexgel (NXGL)?

The current stock price of Nexgel (NXGL) is $2.53 as of April 25, 2025.

What is the market cap of Nexgel (NXGL)?

The market cap of Nexgel (NXGL) is approximately 19.2M.

What is the revenue (TTM) of Nexgel (NXGL) stock?

The trailing twelve months (TTM) revenue of Nexgel (NXGL) is $8,688,000.

What is the net income of Nexgel (NXGL)?

The trailing twelve months (TTM) net income of Nexgel (NXGL) is -$3,463,000.

What is the earnings per share (EPS) of Nexgel (NXGL)?

The diluted earnings per share (EPS) of Nexgel (NXGL) is -$0.50 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Nexgel (NXGL)?

The operating cash flow of Nexgel (NXGL) is -$3,867,000.

What is the profit margin of Nexgel (NXGL)?

The net profit margin of Nexgel (NXGL) is -39.86%.

What is the operating margin of Nexgel (NXGL)?

The operating profit margin of Nexgel (NXGL) is -40.91%.

What is the gross margin of Nexgel (NXGL)?

The gross profit margin of Nexgel (NXGL) is 31.63%.

What is the current ratio of Nexgel (NXGL)?

The current ratio of Nexgel (NXGL) is 2.07, indicating the company's ability to pay short-term obligations.

What is the gross profit of Nexgel (NXGL)?

The gross profit of Nexgel (NXGL) is $2,748,000 on a trailing twelve months (TTM) basis.

What is the operating income of Nexgel (NXGL)?

The operating income of Nexgel (NXGL) is -$3,554,000.

What is Nexgel Inc primarily known for?

Nexgel Inc is known for manufacturing advanced hydrogels using electron beam cross-linked aqueous polymers. Its products are widely used in wound care, transdermal drug delivery, diagnostics, and cosmetic applications.

How does Nexgel Inc produce its hydrogels?

The company employs state-of-the-art manufacturing processes that include proprietary mixing, coating, and electron beam cross-linking techniques. These processes allow Nexgel Inc to create high water content gels tailored to specific application needs.

Which market segments benefit from Nexgel Inc's products?

Nexgel Inc’s products serve multiple market segments including hospital wound care, consumer over-the-counter products, prescription applications, medical devices, and cosmetics. This diversification highlights the versatility of their hydrogel solutions.

What role does proprietary technology play at Nexgel Inc?

Proprietary technology is central to Nexgel Inc’s competitive edge. It enables the company to develop custom gel formulations and maintain consistent quality across varied applications, meeting both medical and consumer market demands.

Is Nexgel Inc's technology validated by regulatory bodies?

Yes, Nexgel Inc’s technology was originally developed and FDA-approved for hospital wound care applications. This regulatory validation underpins the safety and efficacy of their products across various sectors.

How does Nexgel Inc differentiate itself from competitors?

Nexgel Inc differentiates itself through its focus on proprietary manufacturing processes and custom gel formulations. This allows the company to offer versatile and innovative solutions that meet specific client needs in a competitive market.

What are the primary applications of Nexgel Inc's hydrogel products?

The primary applications include wound care management, transdermal drug delivery, medical diagnostics, and cosmetic formulations. Each application leverages the unique properties of high water content, advanced hydrogels to enhance performance and efficacy.

Can Nexgel Inc's hydrogels be adapted for various industrial needs?

Absolutely. Nexgel Inc’s focus on custom solutions means its hydrogels can be specifically engineered to meet the requirements of diverse industries. This adaptability is a key factor in their wide-ranging market applications.